Faber Logo
Skip to main content

Kori Kaufman

Director, Contracts Specialist 

she/her

Faber’s clients benefit from Kori’s more than twenty-five years of contracts experience in the pharmaceutical and biotechnology industries.

Kori assists clients with clinical trial, service, consulting, and related agreements for all stages of therapeutic product and medical device research and development.

Kori’s extensive clinical trial experience includes drafting, negotiating, and coordinating CRO and other vendor agreements, site clinical trial agreements, and informed consent forms for clinical studies ranging from a client’s first Phase 1 clinical study to complex, multinational, pivotal clinical trials with over 450 sites.

Kori previously chaired Faber's Black Civil Rights Education subcommittee as part of Faber’s commitment to equality, diversity, and inclusion.

More about Kori

Contracts Manager

Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)
  • Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
  • Worked with AMRI’s international subsidiaries on corporate governance and compliance
  • While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts

Kori completed doctorate level course work in Anthropology at the University at Albany, State University of New York.

  • Supported numerous Phase 1 through 3 oncology clinical trials of multiple small molecules sponsored by Deciphera Pharmaceuticals, LLC (a member of Ono Pharma), including coordinating, drafting and negotiating clinical trial agreements, clinical service agreements, informed consents, and related agreements for multinational trials involving sites in North America, Europe, South America, Asia, and Australia
  • Supported CG Pharmaceuticals, Inc. in a Phase 1b/2 clinical trial of their novel HDAC inhibitor targeting metastatic pancreatic adenocarcinoma involving approximately 20 sites in the United States
  • Assisted publicly-traded biotech client with US clinical trials at multiple dialysis centers focusing on additional indications of approved nephrology product
  • Assisted multiple clients in obtaining and reviewing advice from local and privacy counsel for clinical trial related agreements in Europe, Asia, and Latin America
  • Drafted and negotiated service agreements with service providers for clinical and preclinical studies, of therapeutic and medical device products, including start-up and master services agreements valued at over $500,000 with large, multinational contract research organizations

Kori presented at MCLE’s 25th Annual Paralegal Conference on the role of contract management in the pharmaceutical and biotech industry.

Related Content

Previous Page
Next Page

Interested in working with Kori?

Our team is eager to learn more about your project

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.